Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond S Lance

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomyChristopher L Amling, Robert H Riffenburgh, Leon Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Elissa C Brown, et al.
Journal of Proteome Research|March 26, 2010
In-depth proteomic analyses of direct expressed prostatic secretionsRichard R Drake, Sarah Elschenbroich, Orlay Lopez-Perez, et al.
Urology|October 31, 2012
NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hans Lilja, O John Semmes, et al.
Proteomics. Clinical Applications|June 19, 2013
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progressionJulius O Nyalwidhe, Lucy R Betesh, Thomas W Powers, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
Molecular & Cellular Proteomics : MCP|September 19, 2012
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancerYunee Kim, Vladimir Ignatchenko, Cindy Q Yao, et al.
European Urology|March 31, 2015
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk CalculatorDonna P Ankerst, Jing Xia, Ian M Thompson, et al.
The Journal of Urology|April 22, 2014
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsiesAlan W Partin, Leander Van Neste, Eric A Klein, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary ProteomesAmanda Khoo, Meinusha Govindarajan, Zhuyu Qiu, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomyChristopher L Amling, Robert H Riffenburgh, Leon Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Elissa C Brown, et al.
Journal of Proteome Research|March 26, 2010
In-depth proteomic analyses of direct expressed prostatic secretionsRichard R Drake, Sarah Elschenbroich, Orlay Lopez-Perez, et al.
Urology|October 31, 2012
NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hans Lilja, O John Semmes, et al.
Proteomics. Clinical Applications|June 19, 2013
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progressionJulius O Nyalwidhe, Lucy R Betesh, Thomas W Powers, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
Molecular & Cellular Proteomics : MCP|September 19, 2012
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancerYunee Kim, Vladimir Ignatchenko, Cindy Q Yao, et al.
European Urology|March 31, 2015
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk CalculatorDonna P Ankerst, Jing Xia, Ian M Thompson, et al.
The Journal of Urology|April 22, 2014
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsiesAlan W Partin, Leander Van Neste, Eric A Klein, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary ProteomesAmanda Khoo, Meinusha Govindarajan, Zhuyu Qiu, et al.
Pageof 4